Correlation Between DiaMedica Therapeutics and Pulmatrix
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Pulmatrix, you can compare the effects of market volatilities on DiaMedica Therapeutics and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Pulmatrix.
Diversification Opportunities for DiaMedica Therapeutics and Pulmatrix
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between DiaMedica and Pulmatrix is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Pulmatrix go up and down completely randomly.
Pair Corralation between DiaMedica Therapeutics and Pulmatrix
Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 6.96 times less return on investment than Pulmatrix. But when comparing it to its historical volatility, DiaMedica Therapeutics is 4.27 times less risky than Pulmatrix. It trades about 0.21 of its potential returns per unit of risk. Pulmatrix is currently generating about 0.35 of returns per unit of risk over similar time horizon. If you would invest 208.00 in Pulmatrix on September 4, 2024 and sell it today you would earn a total of 426.00 from holding Pulmatrix or generate 204.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
DiaMedica Therapeutics vs. Pulmatrix
Performance |
| Timeline |
| DiaMedica Therapeutics |
| Pulmatrix |
DiaMedica Therapeutics and Pulmatrix Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with DiaMedica Therapeutics and Pulmatrix
The main advantage of trading using opposite DiaMedica Therapeutics and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
| Pulmatrix vs. Capricor Therapeutics | Pulmatrix vs. Akari Therapeutics PLC | Pulmatrix vs. Soleno Therapeutics | Pulmatrix vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |